What is Hologic Price-to-Operating-Cash-Flow?
As of today (2024-12-13), Hologic's share price is $75.09.
Hologic's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $5.42. Hence, Hologic's Price-to-Operating-Cash-Flow Ratio for today is 13.86.
The historical rank and industry rank for Hologic's Price-to-Operating-Cash-Flow or its related term are showing as below:
HOLX'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.31 Med: 16.48 Max: 989.32
Current: 13.86
During the past 13 years, Hologic's highest Price-to-Operating-Cash-Flow Ratio was 989.32. The lowest was 6.31. And the median was 16.48.
Hologic's Cash Flow from Operations per share for the
three
months ended in Sep. 2024 was $1.56.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $5.42.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hologic was 28.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -15.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 14.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 22.30% per year.
During the past 13 years, Hologic's highest 3-Year average Operating Cash Flow per Share Growth Rate was 388.90% per year. The lowest was -74.90% per year. And the median was 18.50% per year.
Hologic Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Hologic's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic Price-to-Operating-Cash-Flow Chart
|
Hologic Annual Data
|
|
Trend |
Sep15 |
Sep16 |
Sep17 |
Sep18 |
Sep19 |
Sep20 |
Sep21 |
Sep22 |
Sep23 |
Sep24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
19.62 |
8.23 |
7.70 |
16.43 |
15.06 |
|
Hologic Quarterly Data
|
|
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
16.43 |
17.27 |
17.16 |
15.12 |
15.06 |
Competitive Comparison of Hologic's Price-to-Operating-Cash-Flow
For the Medical Instruments & Supplies subindustry, Hologic's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Hologic's Price-to-Operating-Cash-Flow falls into.
Hologic Price-to-Operating-Cash-Flow Calculation
Hologic's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 75.09 | / | 5.418 |
| = | 13.86 |
Hologic's Share Price of today is $75.09.
Hologic's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Hologic Business Description
Traded in Other Exchanges
Address
250 Campus Drive, Marlborough, MA, USA, 01752
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Executives
| Karleen Marie Oberton |
officer: Corp. VP, Finance & Acconting |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Benjamin Jordan Cohn |
officer: Principal Accounting Officer |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Stephen P Macmillan |
director, officer: President and CEO |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Christiana Stamoulis |
director |
C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY ST, CAMBRIDGE MA 02139 |
| Scott T Garrett |
director |
35 CROSBY DRIVE, BEDFORD MA 01730 |
| Charles J Dockendorff |
director |
COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048 |
| Sally Crawford |
director |
C/O HOLOGIC, INC., BEDFORD MA 01730 |
| Essex D Mitchell |
officer: Div. President, GYN Surgical |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Nanaz Mohtashami |
director |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Jennifer M Schneiders |
officer: President, Diag. Solutions |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Stacey D. Stewart |
director |
5920 WALHONDING ROAD, BETHESDA MD 20816 |
| Elisabeth A Hellmann |
officer: SVP, Human Resources |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Kevin R Thornal |
officer: Div. President, Diagnostics |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| John M. Griffin |
officer: General Counsel |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
| Erik S Anderson |
officer: Div. Pres., Breast & Skeletal |
250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HOLX has been successfully added to your